21,567 followers
Lefamulin may provide a valuable alternative to fluoroquinolones or macrolides for treatment of community-acquired bacterial #pneumonia, an efficacy and safety in a pooled phase 3 clinical trial finds https://t.co/KDOHA8GH8N #BMCPulmMed #WorldPneumoniaDay